[Featured Stock] Russian COVID-19 Vaccine-Related Stock 'HumanN'... Hits Upper Limit on News of Development Team Visiting Korea
[Asia Economy Reporter Park Jihwan] HumanN's stock price surged to the upper limit on the 26th following the news of the visit of the research team that developed the COVID-19 vaccine 'Covivac'.
As of 2:50 PM that day, HumanN was trading at 8,850 KRW, up 29.96% (2,040 KRW) from the previous day.
The strong performance of HumanN's stock is interpreted as a result of the news of the visit to Korea by key researchers, including Aidar Ishmukhametov, the head of the Chumakov Institute, which developed Covivac.
According to related industries, the research team from the Chumakov Institute is preparing to visit Korea next month. Officials planning the visit have currently applied for quarantine exemption approval through the Corporate Immigration Support Center.
Covivac is a COVID-19 vaccine that received approval for use from the Russian Ministry of Health in February. The Chumakov Institute has currently applied to the World Health Organization (WHO) for the official prequalification (PQ) of the Covivac vaccine.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Samsung Electronics Labor-Management Talks End Without Agreement... Central Labor Relations Commission: "Negotiations Resume at 10 a.m. Today" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
In Korea, MP Corporation is in charge of overseeing the Covivac project and signed a memorandum of understanding (MOU) in February for the domestic contract manufacturing of the Covivac vaccine and exclusive distribution rights in ASEAN countries. HumanN is classified as a Covivac-related stock, having invested approximately 7 billion KRW each in Webiotech and MP Corporation.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
